After Hours Summary: USNA +15.4%, MODN +13.2%, LYFT +10.5% higher on earnings; AYX -8.8%, AKAM -7%, CSCO -5.4% lower on earningsAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: USNA +15.4% (also authorizes $150 mln share repurchase program), MODN +13.2%, LYFT +10.5%, CCK +7.8%, OI +6.4%, ENPH +5.9%, URBN +5.9%, RICK +5.8%, STEP +4.6%, THC +3.8%, QGEN +3.6%, MESA +3.5%, GPRE +3.2%, TWTR +2.6%, MAT +2.3%, TWO +2.3%, BW +2.3% (also announces stock offering), RPD +2%, YELP +2%, BKH +0.1%, PRI +0.1% (also raises dividend; approves new buyback),
Companies trading higher in after hours in reaction to news: GNFT +103.8% (positive results from the Ph 2 clinical trial evaluating elafibranor), GMDA +71.6% (presents Phase 3 data on omidubicel; anticipates BLA submission in 2H21), KALV +3.3% (stock offering), MTCH +2.4% (to acquire Hyperconnect for US$1.725 bln in cash and stock), FULT +1.7% (approves $75 mln stock repurchase program), IVZ +1.4% (reports Jan AUM data), KTOS +1.1% (stock offering), WYNN +0.9% (WynnBET receives conditional approval for online sports betting in Tennessee), MRNA +0.7% (announces vaccine supply agreements with Taiwan and Colombia), SRG +0.2% (new CEO), IBM +0.2% (Instacart acquires over 250 patents from IBM), APAM +0.1% (reports Jan AUM data), SQZ +0.1% (stock offering),
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: CPSI -13.4%, AYX -8.8%, ATEN -8.7%, AKAM -7% (also announces organizational changes), PAA -7%, CDAY -6.9%, CSCO -5.4% (also raises dividend), NCR -4%, NGL -3.6%, FMC -3%, DCPH -2.7%, VOYA -2.6%, MTW -2.5%, FISV -1.7%, EXTR -1.4%, WELL -0.9%, REYN -0.8% (also raises dividend), G -0.3% (also announces $500 mln increase to share repurchase auth; and 10% dividend increase), DEI -0.2%, HIW -0.2%,
Companies trading lower in after hours in reaction to news: VNRX -12% (stock offering), XONE -9.2% (stock offering), ENLV -8.7% (announces $10 mln bought deal offering), LMB -7.9% (stock offering), BLDP -6.4% (announces $350 mln bought deal offering), CDAK -4% (stock offering), MREO -2.3% (ADS offering), ONCR -2.2% (stock offering), SNY -0.6% (FDA approves Libtayo as immunotherapy for patients with advanced basal cell carcinoma), VRNS -0.3% (files for mixed securities shelf offering),
Closing Stock Market SummaryEach of the major indices set intraday record highs on Tuesday, but only the Nasdaq Composite (+0.1%) and Russell 2000 (+0.4%) closed at record highs. The S&P 500 (-0.1%) and Dow Jones Industrial Average (-0.03%) snapped their six-session winning streaks with fractional declines.
Today's price action suggested the market was consolidating its February rally in which the S&P 500 rallied more than 5% in the prior six trading sessions. Most sectors flipped between modest gains and losses today, except for the energy sector (-1.5%), which declined 1.5%.
The materials (-0.7%) and consumer discretionary (-0.6%) sectors also underperformed, while the real estate (+0.5%) and communication services (+0.2%) sectors showed relative strength. Broader selling interest was muted, as investors respected the positive macro factors in the market.
To rehash, these factors included increasing COVID-19 vaccination rates and decreasing infection/hospitalization rates, low interest rates, optimism surrounding another fiscal stimulus bill, and better-than-expected earnings reports.
Take-Two Interactive (TTWO 200.31, -13.03, -6.1%) and DuPont (DD 73.48, -2.28, -3.0%) were among the latest companies to exceed earnings expectations and issue upbeat guidance, but the reactions were disappointing. Nucor (NUE 54.68, +0.98, +1.8%) raised Q1 EPS guidance well above consensus estimates due to positive economic trends and robust demand in the steel industry.
Separately, Electronic Arts (EA 146.11, +3.65, +2.6%), a competitor to TTWO, announced plans to acquire Glu Mobile (GLUU 12.67, +3.28, +34.9%) for $12.50/share in a cash deal worth $2.1 billion in enterprise value. The deal was a 36% premium to GLUU's closing price on Feb. 5.
U.S. Treasuries finished little changed in a tight-ranged session. The 2-yr yield increased one basis point to 0.12%, and the 10-yr yield finished flat at 1.16%. The U.S. Dollar Index fell 0.5% to 90.46. WTI crude futures increased 0.7%, or $0.38, to $58.35/bbl.
Reviewing Tuesday's economic data:
- Job openings increased to 6.646 million in December from a revised 6.572 million in November (from 6.527 million).
- The NFIB Small Business Optimism Index decreased to 95.0 in December from 95.9 in November.
Looking ahead, investors will receive the Consumer Price Index for January, the Treasury Budget for January, Wholesale Inventories for December, and the MBA Mortgage Applications Index on Wednesday.
- Russell 2000 +16.4% YTD
- Nasdaq Composite +8.7% YTD
- S&P 500 +4.1% YTD
- Dow Jones Industrial Average +2.5% YTD
Gapping down
In reaction to earnings/guidance:
- KFRC -8.8%, WCC -8.2%, DHT -7.3%, OPCH -7.3% (also announces stock offering), COTY -6.5%, CORT -5.1%, CDK -5%, LMNX -4.9%, CARR -4.8%, TTWO -4.7%, HQY -4.7%, ACM -3.9%, AMKR -3.3%, NUAN -3% (also announces acquisition of Saykara), RAMP -2.6% (also to acquire DataFleets), JKHY -2.6%, NRZ -2.2%, LCII -2.1%, TOT -1.7%, CNC -1.4%
Other news:
- EKSO -20.6% (prices offering of 3,902,440 shares of common stock at $10.25 per share)
- ZOM -18.9% (prices offering of 91,315,790 common shares at $1.90 per share)
- CLF -8.1% (prices offering of 60 mln shares of common stock; gross proceeds for CLF of approximately $326 million)
- LBRT -7.6% (prices offering by selling shareholders of 8.7 mln shares of common stock at $11.45 per share)
- OPCH -7.3% (prices offering of 15 mln shares of common stock at $18.50 per share)
- IPWR -6.2% (prices offering of 1,176,500 shares of common stock at $17.00 per share)
- OSH -5.4% (stock offering)
- IRDM -4.4% (to be added to the S&P MidCap 400)
- AQUA -4.3% (announces the pricing of a secondary public offering of 16,382,793 shares of its common stock by certain institutional shareholders of the company, including certain affiliates of AEA Investors LP, which is expected to result in gross proceeds of approximately $407.1 mln)
- NNOX -3.5% (stock offering)
- SIEN -2.8% (prices offering of 5,410,628 shares of its common stock at $6.75 per share)
- LSPD -2.1% (launches public offering of 7 mln subordinate voting shares),
- OPRX -2% (stock offering)
- LESL -1.8% (stock offering)
- NNDM -1.2% (ADS offering)
Analyst comments:
- ESPR -3.2% (downgraded to Sell from Neutral at Goldman)
- MTDR -1.9% (downgraded to Neutral from Buy at MKM Partners)
- LADR -1.5% (downgraded to Underweight from Neutral at JP Morgan)
Gapping up
In reaction to earnings/guidance:
- SLQT +14.9%, BECN +6.5%, IIVI +5.4%, GT +5.3%, VRNS +5.1% (also announces 3-for-1 stock split), CHGG +4.1%, OMF +3.5%, CAMT +3.1%, IT +2.7%, BBDC +2.4%, HAIN +2.4%, SEE +2.2%, SPG +2.1%, HBI +2%, EPC +1.8%, ARMK +1.8%, MBUU +1.7%, SPGI +1.7%, INCY +1.5%, HMC +1.2%, CGC +1.1%, AVYA +1.1%, BLKB +0.9%, J +0.8%, DD +0.7%, MLM +0.7%
Other news:
- KALV +178.9% (announces "positive" topline data from a Phase 2 clinical trial demonstrating statistically and clinically significant efficacy of KVD900 as an oral on-demand treatment for hereditary angioedema attacks)
- HTBX +62.7% (reports positive interim data of the co's fully-enrolled Phase 2 trial of HS-110)
- GLUU +33.3% (EA to acquire GLUU for $12.50/sh in cash; also reported earnings)
- TLRY +19.3% (established an agreement with Grow Pharma to import and distribute Tilray's medical cannabis products into the United Kingdom)
- IRWD +12.8% (CEO departs),
- COLL +11.9% (to be added to the S&P SmallCap 600)
- GRNV +11.5% (to combine with Helbiz; deal includes $30 mln PIPE investment)
- NCTY +9.4% (enters into a $100 mln SEDA to fund business growth)
- FRLN +8.3% (presents data on its Gaucher Disease and Fabry Disease AAV-Based Gene Therapies)
- ORTX +7.3% (announces new data from several of its hematopoietic stem cell gene therapies in development for neurodegenerative disorders, including interim data on multiple clinical outcomes for OTL-203 in MPS-I, encouraging preliminary biomarker data for OTL-201 in MPS-IIIA and natural history data in MLD)
- IPHA +6.3% (announced new clinical developments for its first-in-class, proprietary investigational asset, lacutamab, an anti-KIR3DL2 cytotoxicity-inducing antibody in development for T-cell lymphomas)
- SAIC +6.3% (awarded $830 mln Army contract for Aviation Systems Engineering Services)
- AVIR +5.8% (announces publication of preclinical data for AT-5270)
- TIGR +5.6% (announces $65 mln private placement of convertible notes)
- IPI +4.3% (announces $50 increase to potash price)
- AFMD +4.2% (Point72 Asset Mgmt discloses 4.8% stake (prior 1.72%))
- VERI +2% (continues international expansion through agreement with Lima, Peru-based commercial radio group, CRP Radios)
- MPWR +1.7% (to be added to the S&P 500)
- TEN +1.3% (Carl Icahn lowers active stake following the recent sale)
- BIDU +1.3% (develops first multi-modal autonomous driving MaaS platform in Guangzhou)
- TGTX +1.3% (license partner Rhizen Pharmaceuticals AG receives FDA accelerated approval for Umbralisib for adult patients with relapsed or refractory MZL & FL)
- AMRN +1.1% (provides update on regulatory review processes for Vascepa in Mainland China and Hong Kong)
Analyst comments:
- TWLO +2.6% (upgraded to Overweight from Neutral at JP Morgan)
- KREF +2.3% (upgraded to Overweight from Neutral at JP Morgan)
- EQR +1.4% (upgraded to Buy from Neutral at BofA Securities)
- HSBC +1% (upgraded to Neutral from Underperform at BofA Securities; upgraded to Sector Perform from Underperform at RBC Capital Mkts)